September 26th 2024
Your daily dose of the clinical news you may have missed.
July 22nd 2024
Participants with AF who used wearable devices reported higher anxiety levels and increased health care usage than nonusers, according to a new study.
May 2nd 2024
April 23rd 2024
Patients with AF aged younger than 65 years have substantial comorbidity burden that may impact their future risk of mortality, reported researchers.
March 25th 2024
Overall, a 33% increased risk of major bleeding was seen, with risk highest during the first 30 days of concomitant use and persistent, but lower, after 6 months.
Smartphone-based ECG Screening Detects More Atrial Fibrillation than Usual Care in American Indian Adults
A new study found that mobile-based ECG screening for AF could improve health outcomes among American Indian adults who have historically endured greater health disparities.
Aspirin without Indication Added to DOAC Therapy Ups Risk for Bleeding
Study authors warn that ASA added to a medication regimen may be unintentional and call on clinicians to assess patients on DOACs for concomitant ASA and deprescribe.
SGLT2 Inhibitor Therapy May Reduce Risk of Atrial Arrhythmias in T2D
A recent meta-analysis suggests some sodium glucose cotransporter-2 inhibitor agents may protect against atrial and ventricular arrhythmias as well as sudden cardiac death in type 2 diabetes patients.
Study: One Alcoholic Drink a Day Linked to Increased Risk of Atrial Fibrillation
People who regularly consume just 1 alcoholic drink a day are at a 16% increased risk of atrial fibrillation compared to those who do not drink alcohol at all, a new study found.
Omega-3s, Vitamin D Fail to Prevent Incident Atrial Fibrillation
AHA 2020: Daily supplementation with 2000 IU of vitamin D3/day and/or 840 mg omega-3 fatty acids/day did not reduce or increase risk of incident atrial fibrillation.
PREVIEW of AHA 2020 Scientific Sessions: Late-breaking Science, Days 4 and 5
Preview days 4 and 5 of the American Heart Association 2020 live late-breaking science sessions. Decide what you need to watch and when.
AHA 2020 Scientific Sessions Preview: Late-breaking Science, Days 1, 2 and 3
What to watch during the AHA 2020 late-breaking science sessions? We break down the first 3 days of clinical trial presentations for you, here.
Seen in the ED Quiz: Biceps Pain and Afib
Patient is a 70-year-old woman who presents with biceps pain for 3 days. History includes atrial fibrillation. What's your diagnosis?
Novel Study Shows Decline in Atrial Fibrillation Deaths, but More Work Needed
Deaths associated with atrial fibrillation have decreased, but it still takes an average of 2 years off a patient's life, according to a first-of-its-kind study.
DOACs Go Head-to-Head on Safety, Efficacy in US Cohort Study
Safety and efficacy of apixaban bested rivaroxaban in analysis of new users from a US nationwide commercial healthcare claims database.
Endurance Training and Atrial Fibrillation: Sex Matters
A large Swedish cohort study suggests that when it come to risk of atrial fibrillation, there are differences in the way women and men respond to endurance training.
Coffee and Atrial Fibrillation: What's the (True) Link?
A new study finds that higher caffeine intake may decrease the risk of patients developing new onset atrial fibrillation.
Afib 2019 Guidelines Update: 5 Questions for Primary Care
Evidence-based revisions to the AHA/ACC/HRS guidelines will affect management of your patients with atrial fibrillation. Do you know how? Find out with a quick quiz.
Top 3 Atrial Fibrillation Studies in 2018
Andexxa, CABANA, and new AF score. Cardiologist and Patient Care author Payal Kohli, MD, highlights 3 pivotal developments from 2018.
EHR Alert Fatigue: An Anticoagulation Example
From "Danger of sepsis" to "Birthday today," the EHR covers it all. Will a popup on prescribing anticoagulation catch on?
Athletes and Atrial Fibrillation: No Longer Synonymous?
A 20-year observational study of nearly 7000 elite athletes found only 0.3% developed atrial fibrillation. Is it time to think differently?
The Opioid Epidemic and AF
Use of opioids in therapeutic doses in a large population of young veterans was linked to new-onset atrial fibrillation in a study reported at the AHA Scientific Sessions 2018.
Stroke Rate Variability in Afib: Much Higher than We Thought!
A new study reveals the notable impact of the variation in published stroke rates on the net clinical benefit of anticoagulation in atrial fibrillation.
New Afib Scoring System: Is it New or Just Different?
The popular CHA2DS2-Vasc stroke risk calculator has its detractors. But will a newly proposed scoring system have a significant clinical impact?
Ablation Complications: Proceed with Caution
Right atrial ablation for atrial flutter is associated with a surprisingly high rate of serious, sometimes fatal, complications. News from ESC 2018.
ARRIVE, ASCEND and the Future of Aspirin
The future role of aspirin in primary prevention of cardiovascular disease is unclear, and not for lack of scrutiny at ESC 2018.
Case in Point: Would You Anticoagulate this Patient?
The patient is an elderly man with ESRD on dialysis who goes into atrial fibrillation during fistula declotting. How to proceed?
Afib and Aflutter: Should We Be “Lumpers” or “Splitters”?
Results of a new study may prompt you to rethink how you approach anticoagulation for these 2 arrhythmias. Are they 1 entity, or 2?
Another Reason to Consider NOACs
A new study clears up a lingering question about the novel oral anticoagulants, VKAs, and risk of MI.
Catheter Ablation Effective for AFib in Adults with Congenital Heart Disease
The first study of its kind found ablation strategies used in normal hearts are safe, effective, and yield good results.
Stroke Knowledge & OAC Preference in Patients with Atrial Fibrillation
Is there a link between stroke knowledge and OAC preferences in patients with AF? According to a new study, yes.
Anticoagulation Brush-up: Q&A with Payal Kohli, MD
Brush up on your oral anticoagulation basics with answers to three key questions we posed to cardiologist and Patient Care board member Payal Kohli, MD.
The CABANA Trial in AF: A Quiz and a Practice Question
Results of the CABANA study (atrial fibrillation) are up for evaluation. How did the trial work and could it change your thoughts on AF treatment?
Antidote for Factor Xa Inhibitors: Approved
And it's very good news for clinicians who routinely recite the pros/cons of direct oral anticoagulation to their patients with atrial fibrillation.
Nuts vs Atrial Fibrillation
Nuts have proven, once again, that they are one of the leading heart-healthy foods.